Silver Sulfadiazine — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	Topical	Apply a thin layer (1-2 mm) to affected area	Once or twice daily	Duration: Until healing occurs (usually 7-14 days) Notes: Clean and debride wound before application. Reapply if cream is wiped off.
Cat	Topical	Apply a thin layer to affected area	Once or twice daily	Duration: Until healing occurs (usually 7-14 days) Notes: Monitor for licking; use Elizabethan collar if necessary.
Horse	Topical	Apply a thin layer to affected area	Once or twice daily	Duration: Until healing occurs Notes: May be used under a bandage. For hoof conditions, apply to cleaned and debrided hoof.
Cattle	Topical	Apply a thin layer to affected area	Once daily	Duration: Until healing occurs Notes: Ensure adequate restraint. For foot rot, apply after cleaning and debriding the lesion.
Small Ruminants	Topical	Apply a thin layer to affected area	Once daily	Duration: Until healing occurs Notes: Use caution in animals with known sulfonamide hypersensitivity.
Rabbit	Topical	Apply a thin layer to affected area	Once or twice daily	Duration: Until healing occurs Notes: Prevent ingestion; use Elizabethan collar if needed.
Birds/Poultry	Topical	Apply a thin layer to affected area	Once or twice daily	Duration: Until healing occurs Notes: For bumblefoot, clean and debride before application.
Exotic/Other	Topical	Apply a thin layer to affected area	Once or twice daily	Duration: Until healing occurs Notes: Species-specific precautions may apply.

Clinical Indications & Species Uses

General Indications

Topical treatment of infected wounds, burns, and skin ulcers in various species

Dog (Canine)

Treatment of infected wounds, burns, and skin ulcers
Management of pyoderma
Adjunct in the treatment of otitis externa (when used in otic preparations)

Cat (Feline)

Treatment of infected wounds, burns, and skin ulcers
Management of feline acne
Adjunct in the treatment of otitis externa

Horse (Equine)

Treatment of infected wounds, burns, and abrasions
Management of thrush (when used in hoof packing)

Cattle (Bovine)

Treatment of infected wounds, burns, and skin infections
Management of foot rot (topical application)

Small Ruminants (Sheep / Goat)

Treatment of infected wounds, burns, and skin infections

Rabbit & Small Mammals

Treatment of infected wounds, burns, and skin infections
Management of pododermatitis (sore hocks)

Avian & Poultry

Treatment of infected wounds and burns
Management of bumblefoot

Exotic & Other Species

Treatment of infected wounds and burns in reptiles, small mammals, and other exotic species

Pharmacology & Mechanism of Action

Drug Class: Topical Antimicrobial | Pharmacological Group: Sulfonamide (silver salt)

Mechanism of Action: Silver sulfadiazine combines the antimicrobial actions of silver and sulfadiazine. The sulfadiazine component inhibits bacterial folic acid synthesis by competitively inhibiting dihydropteroate synthase, thereby blocking the production of tetrahydrofolate, which is essential for bacterial nucleic acid synthesis. The silver moiety binds to bacterial DNA and proteins, causing disruption of the bacterial cell membrane and cell wall, and also interferes with bacterial respiration and electron transport. This dual mechanism provides broad-spectrum activity against many Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa, and also has activity against some fungi and yeast.

Pharmacodynamics: Silver sulfadiazine is bactericidal against susceptible organisms. It acts locally on the skin surface and in superficial wounds. The silver ions are slowly released from the cream base, providing sustained antimicrobial activity. It is particularly effective against Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Klebsiella species. It also has some activity against Candida albicans and dermatophytes. The drug does not penetrate eschar effectively, so debridement is necessary for optimal efficacy. It has low systemic absorption when applied topically to intact skin, but absorption can increase when applied to large burn wounds or denuded areas.

⚡ Pharmacokinetics Summary

Absorption: Minimal systemic absorption occurs after topical application to intact skin. However, absorption can be significant when applied to large surface areas, especially in burns or wounds with compromised skin barrier. In humans, about 10% of sulfadiazine is absorbed, but in veterinary patients, absorption is variable and depends on the extent of skin damage.

Distribution: After absorption, sulfadiazine distributes widely into body tissues and fluids. It crosses the blood-brain barrier and placenta. Silver ions are deposited in the skin and are slowly released. In animals, distribution is not well characterized due to limited systemic use.

Metabolism: Sulfadiazine is metabolized in the liver primarily by acetylation and glucuronidation. The silver component is not metabolized and is excreted unchanged. In animals, metabolism is similar to other sulfonamides.

Excretion: Sulfadiazine and its metabolites are excreted primarily by the kidneys via glomerular filtration and tubular secretion. Silver is excreted in feces and urine, but the majority remains at the application site. In animals, renal excretion is the main route for the sulfadiazine component.

Half-Life: The half-life of sulfadiazine after systemic absorption is approximately 10-12 hours in dogs, 8-10 hours in cats, and 3-5 hours in horses. However, for topical silver sulfadiazine, systemic half-life is not clinically relevant due to minimal absorption.

Bioavailability: Systemic bioavailability is negligible after topical application to intact skin. When applied to large wounds, bioavailability may increase but is still low. Oral bioavailability is not applicable as the drug is not administered systemically.

Protein Binding: Sulfadiazine is approximately 50-70% bound to plasma proteins in dogs and cats. The silver component does not bind significantly to proteins.

Available Formulations & Strengths

Topical Cream 1% (10 mg/g) (Topical)

Topical Ointment 1% (10 mg/g) (Topical)

Topical Solution (for otic use) 1% (10 mg/mL) (Otic)

Contraindications & Clinical Warnings

Contraindications:

Known hypersensitivity to sulfonamides or silver compounds
Use in neonates (especially premature animals) due to risk of kernicterus from sulfadiazine
Use in pregnant animals near term (risk of kernicterus in fetus)
Use on deep puncture wounds or where absorption may be significant without proper veterinary supervision

Warnings & Clinical Precautions:

For topical use only; not for ophthalmic use unless specifically formulated
May cause delayed wound healing in some cases; use with caution in animals with compromised hepatic or renal function
Avoid use on large areas in animals with glucose-6-phosphate dehydrogenase deficiency (rare in animals)
Use with caution in animals with known sulfonamide hypersensitivity
In food animals, observe withdrawal times; not approved for use in animals producing milk for human consumption in some countries
Do not use in animals with known allergy to sulfa drugs
Prolonged use may lead to overgrowth of non-susceptible organisms
In cats, monitor for signs of methemoglobinemia if applied to large areas

Adverse Effects & Reactions

Common:

Local skin irritation
Burning or stinging sensation at application site
Delayed wound healing (with prolonged use)

Serious / Severe:

Systemic absorption leading to sulfonamide toxicity (rare)
Methemoglobinemia (especially in cats and neonates)
Bone marrow suppression (with prolonged use on large areas)
Renal toxicity (with systemic absorption)

Rare:

Allergic contact dermatitis
Leukopenia
Thrombocytopenia
Hepatotoxicity

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Topical enzymes (e.g., collagenase, papain)	Silver may inactivate enzymatic debriding agents; avoid concurrent use.	Moderate
Other topical antimicrobials (e.g., mafenide acetate)	May have additive antimicrobial effects but can also increase local irritation; use with caution.	Mild
Systemic sulfonamides	Potential additive systemic effects if significant absorption occurs; monitor for toxicity.	Moderate

Overdose & Toxicity Management

Signs of Toxicity:

Local irritation
Systemic sulfonamide toxicity (if absorbed): nausea, vomiting, crystalluria, hematuria, anemia, methemoglobinemia
Silver toxicity (argyria) with chronic excessive use

Emergency Treatment Protocol: Remove excess cream by washing the area. For systemic toxicity, provide supportive care: fluid therapy to enhance renal excretion of sulfadiazine, alkalinization of urine may be beneficial, and treat methemoglobinemia with methylene blue if severe. Monitor renal and hepatic function. There is no specific antidote for silver toxicity; symptomatic treatment is recommended.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Silver sulfadiazine is not approved for use in food animals in many countries. Withdrawal times are not established. In the US, extra-label use in food animals requires a withdrawal period determined by a veterinarian, but due to minimal systemic absorption, a zero-day withdrawal is often assigned. However, consult regulatory authorities.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 15-30°C (59-86°F)

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Keep container tightly closed. Protect from light. Do not freeze.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Not FDA-approved for veterinary use; approved for human use as a topical cream.

Extra-Label (Off-Label) Use: In the US, silver sulfadiazine is not FDA-approved for veterinary use, but it is commonly used extra-label under AMDUCA. For food animals, a withdrawal time must be established by a veterinarian. In the EU, similar extra-label use regulations apply.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Silver sulfadiazine is a valuable topical antimicrobial for the management of infected wounds, burns, and skin ulcers in veterinary patients. It is particularly effective against Pseudomonas aeruginosa and other common wound pathogens. The cream formulation is easy to apply and provides a moist wound environment that promotes healing. However, it should be used judiciously to avoid delayed wound healing and the development of bacterial resistance. In animals with large wounds or burns, monitor for systemic absorption and potential sulfonamide toxicity. Always clean and debride the wound before application. In food animals, adhere to withdrawal times and regulatory guidelines. For otic use, use only products specifically formulated for the ear. Consider alternative therapies if the wound does not improve within 7-10 days.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)